Zai Lab Limited ADR (NASDAQ: ZLAB) kicked off on Tuesday, down -3.41% from the previous trading day, before settling in for the closing price of $32.54. Over the past 52 weeks, ZLAB has traded in a range of $13.48-$36.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 2095.12%. While this was happening, its average annual earnings per share was recorded 13.14%. With a float of $98.53 million, this company’s outstanding shares have now reached $99.12 million.
Considering the fact that the conglomerate employs 2175 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 62.95%, operating margin of -109.67%, and the pretax margin is -92.44%.
Zai Lab Limited ADR (ZLAB) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.59%, while institutional ownership is 42.50%. The most recent insider transaction that took place on Oct 02 ’24, was worth 7,645. In this transaction Chief Financial Officer of this company sold 301 shares at a rate of $25.40, taking the stock ownership to the 15,161 shares. Before that another transaction happened on Oct 02 ’24, when Company’s Officer proposed sale 301 for $25.40, making the entire transaction worth $7,645.
Zai Lab Limited ADR (ZLAB) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.71 earnings per share (EPS), higher than consensus estimate (set at -1.04) by 0.33. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.81 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.14% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Take a look at Zai Lab Limited ADR’s (ZLAB) current performance indicators. Last quarter, stock had a quick ratio of 3.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.07, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -1.82 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Compared to the last year’s volume of 0.66 million, its volume of 1.47 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 61.54%. Additionally, its Average True Range was 1.69.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 74.89%, which indicates a significant increase from 59.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.25% in the past 14 days, which was higher than the 53.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.19, while its 200-day Moving Average is $19.70. Nevertheless, the first resistance level for the watch stands at $32.52 in the near term. At $33.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $34.28. If the price goes on to break the first support level at $30.76, it is likely to go to the next support level at $30.09. Should the price break the second support level, the third support level stands at $29.00.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
The company with the Market Capitalisation of 3.12 billion has total of 99,609K Shares Outstanding. Its annual sales at the moment are 266,720 K in contrast with the sum of -334,620 K annual income. Company’s last quarter sales were recorded 100,500 K and last quarter income was -80,280 K.
